05/07/2024
8:13 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:20 PM | Nuvectis Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:17 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
7:37 AM | Mosseri Marlio Charles (Filed by)
Nuvectis Pharma (Subject)
| Form SC 13G/A | |
02/06/2024
7:47 AM | Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
| Form SC 13G | |
01/30/2024
8:01 PM | Nuvectis Pharma (Subject)
Peters Thomas Phineas (Filed by)
| Form SC 13G/A | |
|
01/05/2024
3:30 PM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:31 PM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:39 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:45 AM | Nuvectis Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/12/2023
3:05 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
7:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
7:37 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
7:16 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
8:18 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
5:07 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2023
5:52 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:45 PM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:45 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
5:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
5:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:06 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
7:34 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
7:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
7:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:03 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:04 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
6:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
7:00 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
7:45 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
7:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
7:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
7:59 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:42 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:25 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:15 AM | Hoberman Kenneth (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Gold Mania (Ad) Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential
He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. |
06/20/2023
7:16 AM | Kaplan Matthew L. (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:16 AM | Nuvectis Pharma (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:45 PM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
5:46 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:28 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
8:29 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
6:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
7:22 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
